ID   KNT1_RAT                Reviewed;         430 AA.
AC   P01048; P04081; Q6LDW3;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   24-JUL-2024, entry version 160.
DE   RecName: Full=T-kininogen 1;
DE   AltName: Full=Alpha-1-MAP;
DE   AltName: Full=Major acute phase protein;
DE   AltName: Full=T-kininogen I;
DE   AltName: Full=Thiostatin;
DE   Contains:
DE     RecName: Full=T-kininogen 1 heavy chain;
DE     AltName: Full=T-kininogen I heavy chain;
DE   Contains:
DE     RecName: Full=T-kinin;
DE   Contains:
DE     RecName: Full=T-kininogen 1 light chain;
DE     AltName: Full=T-kininogen I light chain;
DE   Flags: Precursor;
GN   Name=Map1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2413018; DOI=10.1016/s0021-9258(17)38984-6;
RA   Furuto-Kato S., Matsumoto A., Kitamura N., Nakanishi S.;
RT   "Primary structures of the mRNAs encoding the rat precursors for bradykinin
RT   and T-kinin. Structural relationship of kininogens with major acute phase
RT   protein and alpha 1-cysteine proteinase inhibitor.";
RL   J. Biol. Chem. 260:12054-12059(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2806908; DOI=10.1016/0378-1119(89)90342-9;
RA   Anderson K.P., Croyle M.L., Lingrel J.B.;
RT   "Primary structure of a gene encoding rat T-kininogen.";
RL   Gene 81:119-128(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-65.
RX   PubMed=2439509; DOI=10.1016/s0021-9258(18)48080-5;
RA   Fung W.-P., Schreiber G.;
RT   "Structure and expression of the genes for major acute phase alpha 1-
RT   protein (thiostatin) and kininogen in the rat.";
RL   J. Biol. Chem. 262:9298-9308(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-48.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=3818598; DOI=10.1016/s0021-9258(18)61660-6;
RA   Kageyama R., Kitamura N., Ohkubo H., Nakanishi S.;
RT   "Differing utilization of homologous transcription initiation sites of rat
RT   K and T kininogen genes under inflammation condition.";
RL   J. Biol. Chem. 262:2345-2351(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-430.
RX   PubMed=2578992; DOI=10.1016/0014-5793(85)81153-4;
RA   Cole T., Inglis A.S., Roxburgh C.M., Howlett G.J., Schreiber G.;
RT   "Major acute phase alpha 1-protein of the rat is homologous to bovine
RT   kininogen and contains the sequence for bradykinin: its synthesis is
RT   regulated at the mRNA level.";
RL   FEBS Lett. 182:57-61(1985).
RN   [6]
RP   PROTEIN SEQUENCE OF 19-48 AND 376-430, AND PYROGLUTAMATE FORMATION AT
RP   GLN-19.
RX   PubMed=3121623; DOI=10.1016/s0021-9258(19)35448-1;
RA   Enjyoji K., Kato H., Hayashi I., Oh-ishi S., Iwanaga S.;
RT   "Purification and characterization of rat T-kininogens isolated from plasma
RT   of adjuvant-treated rats. Identification of three kinds of T-kininogens.";
RL   J. Biol. Chem. 263:973-979(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 330-430.
RX   PubMed=2108948; DOI=10.1111/j.1349-7006.1990.tb02508.x;
RA   Kanda S., Sugiyama K., Takahashi M., Shumiya S., Tomino S., Nagase S.;
RT   "Identification of a protein increasing in serum of Nagase analbuminemic
RT   rats bearing intestinal tumors as an isotype of T-kininogen.";
RL   Jpn. J. Cancer Res. 81:63-68(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 340-430.
RX   PubMed=7574705; DOI=10.1006/abbi.1995.1472;
RA   Sierra F., Walter R., Vautravers P., Guigoz Y.;
RT   "Identification of several isoforms of T-kininogen expressed in the liver
RT   of aging rats.";
RL   Arch. Biochem. Biophys. 322:333-338(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 375-430.
RX   PubMed=3029068; DOI=10.1016/s0021-9258(18)61638-2;
RA   Kitagawa H., Kitamura N., Hayashida H., Miyata T., Nakanishi S.;
RT   "Differing expression patterns and evolution of the rat kininogen gene
RT   family.";
RL   J. Biol. Chem. 262:2190-2198(1987).
RN   [10]
RP   PROTEIN SEQUENCE OF 376-430.
RX   PubMed=3335530; DOI=10.1016/s0021-9258(19)35447-x;
RA   Enjyoji K., Kato H., Hayashi I., Oh-ishi S., Iwanaga S.;
RT   "Purification and characterization of two kinds of low molecular weight
RT   kininogens from rat (non-inflamed) plasma. One resistant and the second
RT   sensitive to rat glandular kallikreins.";
RL   J. Biol. Chem. 263:965-972(1988).
CC   -!- FUNCTION: Kininogens are plasma glycoproteins with a number of
CC       functions: (1) as precursor of the active peptide bradykinin they
CC       effect smooth muscle contraction, induction of hypotension and increase
CC       of vascular permeability. (2) They play a role in blood coagulation by
CC       helping to position optimally prekallikrein and factor XI next to
CC       factor XII. (3) They are inhibitor of thiol proteases.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space.
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- INDUCTION: In response to an inflammatory stimulant. T-kininogen II
CC       synthesis is induced and the plasma concentration of T-kininogen I is
CC       raised.
CC   -!- PTM: As T-kinin is preceded by a Met instead of an Arg or Lys, it is
CC       not released from its precursor by either tissue or plasma kallikrein.
CC   -!- MISCELLANEOUS: Rats express four types of kininogens: the classical HMW
CC       and LMW kininogens produced by alternative splicing of the same gene,
CC       and two additional LMW-like kininogens: T-I and T-II.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M11883; AAA41489.1; -; mRNA.
DR   EMBL; M16454; AAA41568.1; -; Genomic_DNA.
DR   EMBL; M14356; AAA41492.1; -; Genomic_DNA.
DR   EMBL; X02299; CAA26162.1; ALT_SEQ; mRNA.
DR   PIR; A01285; KGRTM.
DR   PIR; A01286; KGRTT1.
DR   PIR; A23897; A23897.
DR   PIR; A27115; A27115.
DR   AlphaFoldDB; P01048; -.
DR   SMR; P01048; -.
DR   MEROPS; I25.019; -.
DR   GlyConnect; 604; 6 N-Linked glycans.
DR   GlyCosmos; P01048; 4 sites, 11 glycans.
DR   GlyGen; P01048; 5 sites, 11 N-linked glycans (1 site).
DR   PhosphoSitePlus; P01048; -.
DR   jPOST; P01048; -.
DR   AGR; RGD:2980; -.
DR   InParanoid; P01048; -.
DR   PhylomeDB; P01048; -.
DR   PRO; PR:P01048; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005576; C:extracellular region; IBA:GO_Central.
DR   GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR   GO; GO:0030195; P:negative regulation of blood coagulation; IBA:GO_Central.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0042311; P:vasodilation; IEA:UniProtKB-KW.
DR   CDD; cd00042; CY; 3.
DR   Gene3D; 3.10.450.10; -; 3.
DR   InterPro; IPR000010; Cystatin_dom.
DR   InterPro; IPR046350; Cystatin_sf.
DR   InterPro; IPR027358; Kininogen-type_cystatin_dom.
DR   InterPro; IPR050735; Kininogen_Fetuin_HRG.
DR   InterPro; IPR018073; Prot_inh_cystat_CS.
DR   PANTHER; PTHR13814; FETUIN; 1.
DR   PANTHER; PTHR13814:SF12; KININOGEN-1; 1.
DR   Pfam; PF00031; Cystatin; 3.
DR   SMART; SM00043; CY; 3.
DR   SUPFAM; SSF54403; Cystatin/monellin; 3.
DR   PROSITE; PS00287; CYSTATIN; 2.
DR   PROSITE; PS51647; CYSTATIN_KININOGEN; 3.
PE   1: Evidence at protein level;
KW   Acute phase; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Protease inhibitor; Pyrrolidone carboxylic acid; Reference proteome;
KW   Repeat; Secreted; Signal; Thiol protease inhibitor; Vasoactive;
KW   Vasodilator.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:3121623"
FT   CHAIN           19..430
FT                   /note="T-kininogen 1"
FT                   /id="PRO_0000006699"
FT   CHAIN           19..375
FT                   /note="T-kininogen 1 heavy chain"
FT                   /id="PRO_0000006700"
FT   PEPTIDE         376..386
FT                   /note="T-kinin"
FT                   /id="PRO_0000006701"
FT   CHAIN           387..430
FT                   /note="T-kininogen 1 light chain"
FT                   /id="PRO_0000006702"
FT   DOMAIN          28..131
FT                   /note="Cystatin kininogen-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DOMAIN          150..253
FT                   /note="Cystatin kininogen-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DOMAIN          272..375
FT                   /note="Cystatin kininogen-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   REGION          411..430
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         19
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:3121623"
FT   CARBOHYD        82
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        168
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        204
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        326
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        28..404
FT                   /note="Interchain (between heavy and light chains)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        83..94
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        107..125
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        141..144
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        205..217
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        228..247
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        263..266
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        327..339
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        350..369
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   CONFLICT        7
FT                   /note="L -> V (in Ref. 5; CAA26162)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        19
FT                   /note="Q -> E (in Ref. 6; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        61
FT                   /note="E -> K (in Ref. 1; AAA41489)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="K -> R (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        166
FT                   /note="F -> S (in Ref. 1; AAA41489)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        179..181
FT                   /note="REV -> TKI (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="S -> F (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        214
FT                   /note="R -> H (in Ref. 5; CAA26162)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257
FT                   /note="E -> S (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        287
FT                   /note="Q -> R (in Ref. 5; CAA26162)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        389
FT                   /note="R -> Q (in Ref. 2; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        414
FT                   /note="R -> G (in Ref. 2; no nucleotide entry and 5;
FT                   CAA26162)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        420
FT                   /note="D -> E (in Ref. 5; CAA26162)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        421
FT                   /note="H -> R (in Ref. 5; CAA26162 and 7; no nucleotide
FT                   entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        430
FT                   /note="P -> S (in Ref. 1; AAA41489, 6; AA sequence, 8, 9
FT                   and 10; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   430 AA;  47775 MW;  FEBBF28FA44793C3 CRC64;
     MKLITILLLC SRLLPSLAQE EGAQELNCND ETVFQAVDTA LKKYNAELES GNQFVLYRVT
     EGTKKDGAET LYSFKYQIKE GNCSVQSGLT WQDCDFKDAE EAATGECTTT LGKKENKFSV
     ATQICNITPG KGPKKTEEDL CVGCFQPIPM DSSDLKPVLK HAVEHFNNNT KHTHLFALRE
     VKSAHSQVVA GMNYKIIYSI VQTNCSKEDF PSLREDCVPL PYGDHGECTG HTHVDIHNTI
     AGFSQSCDLY PGDDLFELLP KNCRGCPREI PVDSPELKEA LGHSIAQLNA QHNHIFYFKI
     DTVKKATSQV VAGVIYVIEF IARETNCSKQ SKTELTADCE TKHLGQSLNC NANVYMRPWE
     NKVVPTVRCQ ALDMMISRPP GFSPFRLVRV QETKEGTTRL LNSCEYKGRL SKARAGPAPD
     HQAEASTVTP
//
